Moreover, we anticipate further pharmacovigilance studies, cohort analyses, and clinical trials in the future to develop evidence-based treatment strategies for patients experiencing GLP-1 RA-induced AP
About the study The phase 3a, multicenter, randomized, double-blind, placebo- and active-controlled REDEFINE 1 trial enrolled 3,417 adults across 22 countries
PMID: 22338093
Current clinical strategies for the management of PDN include glycolic control and treatment with drugs such as tricyclic compounds, serotonin noradrenalin reuptake inhibitors, -lipoic acid, anticonvulsants, opiates, membrane stabilizers and topical capsaicin
The specifics of each pen vary from one medication to anotherdifferent button placements, different hold times, different click patterns